Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Personalis, Inc.PSNL · Entity 4572 | Director · Chief Executive Officer | September 18, 2026 | September 22, 2026 |
| VERACYTE, INC.VCYT · Entity 2018 | President and COO | June 03, 2019 | June 05, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Personalis, Inc.
Report date September 18, 2026 · Filed September 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 228,527 |
Reported balance
After 2026-09-18 transaction · row 1
1 source rowRow 1 · 2026-09-18 · Sale · Disposed 7,459 · Balance 228,527 F1: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units.
VERACYTE, INC.
Report date June 03, 2019 · Filed June 05, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 28,258 |
Reported balance
After 2019-06-03 transaction · row 1
1 source rowRow 1 · 2019-06-03 · Tax withholding · Disposed 456 · Balance 28,258 F1: The reporting person is reporting the withholding of 456 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 918 Restricted Stock Units granted on March 2, 2018 and does not represent a sale by the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person is reporting the withholding of 456 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 918 Restricted Stock Units granted on March 2, 2018 and does not represent a sale by the reporting person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 31, 2018 Filed Nov 1, 2018 21:07 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 3,500 | $13.00 | $45,500.00 |
DisclosureSEC source: 0001384101-18-000080 · wf-form4_154110641114738.xml · nonDerivative · entry 2 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,455 F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 25, 2018. Read SEC document |
| October 31, 2018 Filed Nov 1, 2018 21:07 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 3,500 | $2.36 | $8,260.00 |
DisclosureSEC source: 0001384101-18-000080 · wf-form4_154110641114738.xml · nonDerivative · entry 1 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,955 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 25, 2018. Read SEC document |
| August 09, 2018 Filed Aug 10, 2018 21:10 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 7,500 | $0.00 Strike: $2.36 | $0.00 |
DisclosureSEC source: 0001384101-18-000070 · wf-form4_153393541595179.xml · derivative · entry 7 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,500 Underlying: Common Stock · 7,500 shares Expires 2021-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 25, 2018. F3 · derivative.exercise_date: The option became exercisable in full upon the date of the grant on February 23, 2011. Read SEC document |
| August 09, 2018 Filed Aug 10, 2018 21:10 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 8,263 | $0.00 Strike: $2.36 | $0.00 |
DisclosureSEC source: 0001384101-18-000070 · wf-form4_153393541595179.xml · derivative · entry 6 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,263 shares Expires 2010-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 25, 2018. F2 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on September 28, 2011, and the remaining shares vested at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| August 09, 2018 Filed Aug 10, 2018 21:10 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 4,237 | $0.00 Strike: $2.36 | $0.00 |
DisclosureSEC source: 0001384101-18-000070 · wf-form4_153393541595179.xml · derivative · entry 5 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,237 shares Expires 2020-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 25, 2018. F2 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on September 28, 2011, and the remaining shares vested at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| August 09, 2018 Filed Aug 10, 2018 21:10 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 20,000 | $12.00 | $240,000.00 |
DisclosureSEC source: 0001384101-18-000070 · wf-form4_153393541595179.xml · nonDerivative · entry 4 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,455 F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 25, 2018. Read SEC document |
| August 09, 2018 Filed Aug 10, 2018 21:10 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 7,500 | $2.36 | $17,700.00 |
DisclosureSEC source: 0001384101-18-000070 · wf-form4_153393541595179.xml · nonDerivative · entry 3 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 25, 2018. Read SEC document |
| August 09, 2018 Filed Aug 10, 2018 21:10 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 8,263 | $2.36 | $19,500.68 |
DisclosureSEC source: 0001384101-18-000070 · wf-form4_153393541595179.xml · nonDerivative · entry 2 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,955 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 25, 2018. Read SEC document |
| August 09, 2018 Filed Aug 10, 2018 21:10 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 4,237 | $2.36 | $9,999.32 |
DisclosureSEC source: 0001384101-18-000070 · wf-form4_153393541595179.xml · nonDerivative · entry 1 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,692 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 25, 2018. Read SEC document |
| July 24, 2018 Filed Jul 24, 2018 22:14 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $0.80 | $0.00 |
DisclosureSEC source: 0001384101-18-000064 · wf-form4_153247047852279.xml · derivative · entry 3 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2020-03-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 25, 2018. F2 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on March 15, 2011, and the remaining shares vested at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| July 24, 2018 Filed Jul 24, 2018 22:14 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 10,000 | $11.00 | $110,000.00 |
DisclosureSEC source: 0001384101-18-000064 · wf-form4_153247047852279.xml · nonDerivative · entry 2 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,455 F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 25, 2018. Read SEC document |
| July 24, 2018 Filed Jul 24, 2018 22:14 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 10,000 | $0.80 | $8,000.00 |
DisclosureSEC source: 0001384101-18-000064 · wf-form4_153247047852279.xml · nonDerivative · entry 1 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 25, 2018. Read SEC document |
| July 06, 2018 Filed Jul 9, 2018 23:03 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 32,430 | $0.00 Strike: $0.80 | $0.00 |
DisclosureSEC source: 0001384101-18-000056 · wf-form4_153117737728109.xml · derivative · entry 6 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 32,430 shares Expires 2020-03-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 25, 2018. F5 · derivative.exercise_date: The option became exercisable as to 25% of the shares on March 15, 2011, and the remaining shares vested at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| July 06, 2018 Filed Jul 9, 2018 23:03 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 32,430 | $10.00 | $324,439.45 |
DisclosureSEC source: 0001384101-18-000056 · wf-form4_153117737728109.xml · nonDerivative · entry 4 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,455 F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 25, 2018. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F4 · price: Represents weighted average sales price. Sale prices for the transactions range from $9.79 to $10.05. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| July 06, 2018 Filed Jul 9, 2018 23:03 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 32,430 | $0.80 | $25,944.00 |
DisclosureSEC source: 0001384101-18-000056 · wf-form4_153117737728109.xml · nonDerivative · entry 3 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,885 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 25, 2018. Read SEC document |
| July 05, 2018 Filed Jul 9, 2018 23:03 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 17,570 | $0.00 Strike: $0.80 | $0.00 |
DisclosureSEC source: 0001384101-18-000056 · wf-form4_153117737728109.xml · derivative · entry 5 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,430 Underlying: Common Stock · 17,570 shares Expires 2020-03-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 25, 2018. F5 · derivative.exercise_date: The option became exercisable as to 25% of the shares on March 15, 2011, and the remaining shares vested at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| July 05, 2018 Filed Jul 9, 2018 23:03 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 17,570 | $9.96 | $174,948.00 |
DisclosureSEC source: 0001384101-18-000056 · wf-form4_153117737728109.xml · nonDerivative · entry 2 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,455 F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 25, 2018. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $9.91 to $10.00. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| July 05, 2018 Filed Jul 9, 2018 23:03 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 17,570 | $0.80 | $14,056.00 |
DisclosureSEC source: 0001384101-18-000056 · wf-form4_153117737728109.xml · nonDerivative · entry 1 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,025 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 25, 2018. Read SEC document |
| June 19, 2018 Filed Jun 19, 2018 22:17 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 9,491 | $0.00 Strike: $0.80 | $0.00 |
DisclosureSEC source: 0001384101-18-000052 · wf-form4_152944665945704.xml · derivative · entry 6 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 9,491 shares Expires 2020-03-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 16, 2017. F5 · derivative.exercise_date: The option became exercisable as to 25% of the shares on March 15, 2011, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| June 19, 2018 Filed Jun 19, 2018 22:17 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 9,491 | $9.05 | $85,880.26 |
DisclosureSEC source: 0001384101-18-000052 · wf-form4_152944665945704.xml · nonDerivative · entry 4 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,455 F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 16, 2017. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F4 · price: Represents weighted average sales price. Sale prices for the transactions range from $9.00 to $9.17. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| June 19, 2018 Filed Jun 19, 2018 22:17 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 9,491 | $0.80 | $7,592.80 |
DisclosureSEC source: 0001384101-18-000052 · wf-form4_152944665945704.xml · nonDerivative · entry 3 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,946 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 16, 2017. Read SEC document |
| June 15, 2018 Filed Jun 19, 2018 22:17 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 10,509 | $0.00 Strike: $0.80 | $0.00 |
DisclosureSEC source: 0001384101-18-000052 · wf-form4_152944665945704.xml · derivative · entry 5 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,491 Underlying: Common Stock · 10,509 shares Expires 2020-03-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 16, 2017. F5 · derivative.exercise_date: The option became exercisable as to 25% of the shares on March 15, 2011, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| June 15, 2018 Filed Jun 19, 2018 22:17 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 10,509 | $9.00 | $94,584.15 |
DisclosureSEC source: 0001384101-18-000052 · wf-form4_152944665945704.xml · nonDerivative · entry 2 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,455 F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 16, 2017. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $9.00 to $9.01. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| June 15, 2018 Filed Jun 19, 2018 22:17 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 10,509 | $0.80 | $8,407.20 |
DisclosureSEC source: 0001384101-18-000052 · wf-form4_152944665945704.xml · nonDerivative · entry 1 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,964 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 16, 2017. Read SEC document |
| March 03, 2018 Filed Mar 6, 2018 01:00 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 2,245 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-18-000018 · wf-form4_152029799414522.xml · nonDerivative · entry 2 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,455 F2 · shares: The reporting person is reporting the withholding of 2,245 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 6,667 Restricted Stock Units granted on March 3, 2017. The reporting person did not sell or otherwise dispose of any of the shares reported on this Form 4. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 01:00 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantStock Option (right to buy) · Derivative | 110,250 | $0.00 Strike: $5.98 | $0.00 |
DisclosureSEC source: 0001384101-18-000018 · wf-form4_152029799414522.xml · derivative · entry 3 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,250 Underlying: Common Stock · 110,250 shares Expires 2028-03-02 F3 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on March 3, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 01:00 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 14,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-18-000018 · wf-form4_152029799414522.xml · nonDerivative · entry 1 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,700 F1 · shares: Restricted stock units (RSUs) awarded on March 2, 2018 vest 25% on March 2, 2019, and the remaining vest at a rate of 3/48 on each quarterly anniversary thereafter subject to continuing employment of the Reporting Person on each vesting date. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 21:14 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 20,000 | $0.80 Strike: $0.80 | $16,000.00 |
DisclosureSEC source: 0001384101-17-000060 · wf-form4_150715162971566.xml · derivative · entry 3 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 20,000 shares Expires 2020-03-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option became exercisable as to 25% of the shares on March 15, 2011, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 21:14 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 20,000 | $9.00 | $180,000.00 |
DisclosureSEC source: 0001384101-17-000060 · wf-form4_150715162971566.xml · nonDerivative · entry 2 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 F2 · security: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 16, 2017. F3 · price: Represents actual sale price. F1 · balance_after: Includes an aggregate of 20,000 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 21:14 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 20,000 | $0.80 | $16,000.00 |
DisclosureSEC source: 0001384101-17-000060 · wf-form4_150715162971566.xml · nonDerivative · entry 1 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes an aggregate of 20,000 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. Read SEC document |
| March 03, 2017 Filed Mar 6, 2017 22:08 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantStock Option (right to buy) · Derivative | 80,000 | $0.00 Strike: $9.05 | $0.00 |
DisclosureSEC source: 0001384101-17-000018 · wf-form4_148883810694341.xml · derivative · entry 2 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2027-03-03 F2 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on March 3, 2018, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| March 03, 2017 Filed Mar 6, 2017 22:08 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-17-000018 · wf-form4_148883810694341.xml · nonDerivative · entry 1 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 F1 · shares: Restricted stock units awarded on March 3, 2017 and 1/3 of the award vest each year for the following 3 years. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.